AutoICD API

105494-9

Clinical

Men who are tested for prostate cancer using the PSA (prostate specific antigen) test, about 30% who have an abnormal PSA turn out not to have cancer

LOINC 6-Axis Classification

Component

Men who are tested for prostate cancer using the PSA (prostate specific antigen) test, about 30% who have an abnormal PSA turn out not to have cancer

Property

Find

Time Aspect

Pt

System

^Patient

Scale Type

Ord

Method Type

N/A

Details

Class

PHENX

Order/Observation

Observation

Short Name

Chance prostate cancer

Related Names

abnabnormAgChance prostate cancerFindingFindingsgamma-seminoproteinkallikrein-3OrdinalPhenXPoint in timeQLQualQualitativeRandomScreenSpecWorld Heatlth Organization

Frequently Asked Questions

What is LOINC code 105494-9?

LOINC code 105494-9 identifies "Men who are tested for prostate cancer using the PSA (prostate specific antigen) test, about 30% who have an abnormal PSA turn out not to have cancer". It measures Men who are tested for prostate cancer using the PSA (prostate specific antigen) test, about 30% who have an abnormal PSA turn out not to have cancer in ^Patient.

What does 105494-9 measure?

This code measures Men who are tested for prostate cancer using the PSA (prostate specific antigen) test, about 30% who have an abnormal PSA turn out not to have cancer in ^Patient. It belongs to the PHENX class in the LOINC classification.

What is LOINC?

LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.